2020
DOI: 10.3233/fi-2020-1943
|View full text |Cite
|
Sign up to set email alerts
|

Optimal Personalised Treatment Computation through In Silico Clinical Trials on Patient Digital Twins*

Abstract: In Silico Clinical Trials (ISCT), i.e. clinical experimental campaigns carried out by means of computer simulations, hold the promise to decrease time and cost for the safety and efficacy assessment of pharmacological treatments, reduce the need for animal and human testing, and enable precision medicine. In this paper we present methods and an algorithm that, by means of extensive computer simulation-based experimental campaigns (ISCT) guided by intelligent search, optimise a pharmacological treatment for an … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
2

Relationship

4
6

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 70 publications
0
8
0
Order By: Relevance
“…Also, in order to further increase the size of the areas we can manage, we plan to hybridise our approach with iterative improvement techniques like local-search and meta-heuristic methods (see, e.g., [58,59,60]) specially suited for large instances (e.g., those in [61]), of course sacrificing optimality guarantees. Finally, we aim at reducing the need of linear constraint over-approximations by exploiting simulation-based approaches (e.g., [62,63,64,65]) driven by intelligent search (e.g., [66,67]).…”
Section: Discussionmentioning
confidence: 99%
“…Also, in order to further increase the size of the areas we can manage, we plan to hybridise our approach with iterative improvement techniques like local-search and meta-heuristic methods (see, e.g., [58,59,60]) specially suited for large instances (e.g., those in [61]), of course sacrificing optimality guarantees. Finally, we aim at reducing the need of linear constraint over-approximations by exploiting simulation-based approaches (e.g., [62,63,64,65]) driven by intelligent search (e.g., [66,67]).…”
Section: Discussionmentioning
confidence: 99%
“…As the digital twin works in an autonomous virtual world, it can be studied without impacting the physical structure and biological system. DT, keep the promise to minimize time and cost for the safety and efficacy evaluation of pharmacological drugs, reduce the need for humans and other animals testing, and allow precision medicine (Sinisi et al, 2020). The concept of digital twin (DT) is to create stochastic simulations to produce future "what if" scenarios (Fuller et al, 2020) to improve performance and prevent design flaws.…”
Section: Fig 1: Mechanism Of Actionmentioning
confidence: 99%
“…Together with the model by (37) a previous version of the model by (38) formed the basis for the development of computational tools to enable in silico clinical trials in reproductive endocrinology (39,40). In particular, by introducing variability into model parameters (41)(42)(43), the authors could analyze inter-individual variability in the cycle and automatically synthesize, by means of artificial intelligence guided by patient digital twins, optimal personalized treatments for the patients at hand (44). However, the tools could only be applied to the downregulation phase before follicular stimulation, because the feedback mechanisms from the ovaries to the pituitary were not implemented in the modified model.…”
Section: Mathematical Modeling Of the Female Menstrual Cyclementioning
confidence: 99%